Total meso-esophagogastrectomy in surgically resectable Siewert type II-III junctional gastric cancer: Safety and long term oncologic outcome
Journal Title: Journal of Cancer Research & Therapy - Year 2014, Vol 2, Issue 9
Abstract
Aim: To analyze our experience confronting meso-esophagogastric resection (transhiatally extended total gastrectomy en-bloc with its inviolate primitive dorsal and ventral mesenterium) to less radical planes of surgery (intra-mesoesophagogastric and muscularis propria planes), in the multimodal management of junctional Siewert II/III resectable gastric cancer. Methods: 138 patients with stage I-III/C type II-III Siewert junctional cancers were enrolled. Proximal and distal marginal clearance, closest meso-esophageal resection margin (CRM), volume in mm3 of meso-esophageal tissue around the tumor, R0 resections rate, number of lymph nodes harvested and five years overall and disease-free survival were recorded for each plane of surgery. Results: Mortality and morbidity were 3.6% and 22.4% respectively; operative length was 235 ± 23 min.; mean blood loss was 195 ± 53cc. Mean meso-esophageal tissue volume including tumor was 35,157 mm3 for meso-esophagogastric resections, 25,397 mm3 for intra-mesoesophagogastric resections and 20,531 mm3 for “muscularis propria” resections, all statistically significant (p < 0.05). Mean follow-up was 40.3 months. Five years overall survival was 52.2% for meso-esophagogastric resection, 45% for intra-mesoesophagogastric and 35.2% for muscularis propria resections, all statistically significant; the difference was particularly enhanced in stage II-IIIA/B (56.2%, 47.8% and 30% for meso-esophagogastric, intra-meso-esophagogastric and muscularis propria planes respectively). On multivariate analysis, meso-esophagogastric plane of resection, pCR after neo-adjuvant chemo-radiation, R0, CRM > 1mm and pN0 were associated with increased recurrence-free survival. Conclusions: When compared to less extensive planes of surgery, transhiatally extended total meso-esophagogastrectomy confers a survival advantage in the intermediate stages of Siewert type II-III junctional gastric cancer, increasing R0 resection rate, decreasing CRM < 1mm and enhancing lymph node harvesting, with consequent impact on loco-regional control and survival; differently, in the extreme stages (I and IIIC N + patients), total meso-esophagogastrectomy is ineffective in altering the standard oncologic outcome. In our experience, total meso-esophagogastrectomy proved to be safe and oncologically effective, especially in stage II-IIIA/B, representing a pivotal part of multimodal management of type II/III EGJ cancers.
Authors and Affiliations
Siani LM
Keywords
Related Articles
- EP ID EP548552
- DOI 10.14312/2052-4994.2014-23
- Views 57
- Downloads 0
Variability in the induction of alkaline phosphatase by histone deacetylase inhibitors in bladder and colon cancer cell lines
Induction of alkaline phosphatase activity has provided a convenient marker for differentiation of colon cancer cells. The degree to which different histone deacetylase inhibitors induce alkaline phosphatase and dipeptid...
Economic evaluation of monoclonal antibody in the management of colorectal cancer
Objective: This study aims to determine the cost of colorectal cancer (CRC) management and compare the cost effectiveness of cetuximab and bevacizumab in the management of CRC. Method: This economic evaluation study from...
The first American cancer patient to receive dicycloplatin chemotherapy: A case report
Dicycloplatin (DCP), an effective platinum drug, was developed in China and approved by Chinese FDA in 2012. Its side effects are more bearable than those of cisplatin and carboplatin. The bladder cancer patient presente...
A retrospective study of survival in breast cancer patients undergoing deuterium depletion in addition to conventional therapies
There is increasing evidence that the heavy isotope of hydrogen, deuterium (D), has a pivotal role in cell signalling and that its depletion through the replacement of normal drinking water with deuterium-depleted water...
Contributions of stochastic events to biological evolution and cancer
Stochastic genetic and epigenetic events have been fundamental in contributing to the development of manifold life-forms, past and present. The development of malignant cell clones and the role of stochasticity as a driv...